Abu-Amer Y, Ross F P, Edwards J, Teitelbaum S L
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Clin Invest. 1997 Sep 15;100(6):1557-65. doi: 10.1172/JCI119679.
Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF. Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS. An anti-TNF antibody blocks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro. Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo. In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor. Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.
慢性骨感染,如牙周炎所伴有的,常因严重的骨质溶解而复杂化。虽然脂多糖(LPS)被认为是溶骨性病变发病机制的核心,但这种细菌衍生分子促进骨吸收的机制尚不清楚。我们发现LPS诱导骨髓巨噬细胞(BMMs)表达c-src,一种原癌基因产物,我们证明它是破骨细胞表型形成的特异性标志物。接下来,我们研究了LPS诱导c-src的可能可溶性介质。在测试的多种破骨细胞生成细胞因子中,只有肿瘤坏死因子-α(TNF-α)反映了LPS增强c-src的作用。提示LPS增强c-src是由TNF介导的,内毒素依次诱导BMMs表达TNF,随后是c-src。来自注射LPS小鼠的培养BMMs中TNF和c-src的表达反映了暴露于循环内毒素的持续时间,表明内毒素在体内的作用也是由TNF介导的。与这些发现一致,沙利度胺(拮抗TNF作用)减弱了LPS对c-src的诱导。抗TNF抗体阻断LPS对c-src mRNA的增强作用,证实了该细胞因子在体外的调节作用。使用TNF受体缺失小鼠的BMMs,我们证明TNF诱导c-src是通过细胞因子的p55受体而非p75受体传递的。最重要的是,给野生型小鼠注射LPS会促使破骨细胞前体分化,表现为体外培养的骨髓中大量破骨细胞生成,以及体内大量表达破骨细胞标志物抗酒石酸酸性磷酸酶的骨髓驻留细胞。相比之下,LPS在缺乏p55 TNF受体的小鼠中不会显著增强破骨细胞增殖,证实LPS诱导的破骨细胞生成在体内是通过该受体由TNF介导的。因此,针对TNF和/或其p55受体的治疗方法可作为预防慢性细菌感染骨质溶解的一种手段。